Hyperpolarized 129Xe MRI for Imaging Pulmonary Function

PHASE2RecruitingINTERVENTIONAL
Enrollment

445

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Interstitial Lung Disease
Interventions
DRUG

Hyperpolarized 129Xenon Gas

Hyperpolarized 129Xenon Gas will be administered in multiple doses in volumes that are tailored to the subject's total lung capacity (TLC) followed by a breath hold of up to 15 seconds. Subsequent 129Xe doses will only be administered once the subject is ready to proceed.

Trial Locations (1)

27710

RECRUITING

Duke University Medical Center, Durham

All Listed Sponsors
lead

Bastiaan Driehuys

OTHER